Replimune Announces the Departure of Dr. Otello Stampacchia from its Board of Directors
WOBURN, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) — Replimune Group Inc. (NASDAQ: REPL), a clinical…
Month: January 2022
Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO Transition
– Company to prioritize industry-leading clinical-stage programs, AXO-AAV-GM1 and AXO-AAV-GM2, the first potential disease-modifying therapies…
Ensysce Biosciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
SAN DIEGO, Jan. 31, 2022 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
Inventiva receives a €4 million milestone payment from AbbVie for cedirogant Phase IIb initiation
Daix (France), Long Island City (New York, United States), January 31, 2022 – Inventiva (Euronext…
Asure’s Payroll Fintech Powers New Treasury System to Deliver Added Value to Business Customers
AUSTIN, Texas, Jan. 31, 2022 (GLOBE NEWSWIRE) — Asure Software, Inc., (Nasdaq: ASUR), a leading…
Money Line Sports Launches New Online Sportsbook on FansUnite’s Chameleon iGaming Platform
The platform featuring FansUnite’s proprietary white-label wagering technology goes live today in regulated markets Vancouver,…
CORRECTING and REPLACING Migdal Insurance Commits to Invest in Doral Renewables’ Mammoth South Project
Migdal Insurance, Israel’s leading insurance company, has committed to invest up to $75 million into…
Harris Williams Advises Ntiva on its Sale to PSP Partners
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it…
Business Combination of SES and Ivanhoe Capital Acquisition Corp. Expected to be Approved by Shareholders
IVAN shareholders expected to approve business combination at Extraordinary General Meeting to be held on…
KBRA Assigns Preliminary Ratings to Fannie Mae’s CAS 2022-R02
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 65 classes from Connecticut Avenue Securities, Series 2022-R02…
Banc of California Hires Education Finance Expert to Bolster Charter School Practice
SANTA ANA, Calif.–(BUSINESS WIRE)–Banc of California, Inc. (NYSE: BANC) today announced that its wholly-owned subsidiary,…
K2 Scientific Supports Medical Advancements with Value-Driven Product Line at Critical Juncture
CHARLOTTE, N.C.–(BUSINESS WIRE)–K2 Scientific is doubling its warehouse space for the second time in two…
CPA Firm Issues SOC 2 – Type 2 Report at Tegrita
TORONTO–(BUSINESS WIRE)–Tegrita, a full-stack marketing technology consulting firm, today announced that the company has successfully…
GSM Deal City New Online Startup Offers Cheat Sheet to Record Consumer Inflation and Sustainability
HENDERSON, Nevada–(BUSINESS WIRE)–With US Consumer Inflation at 7% – the biggest rise in almost 40…
H5 Data Centers Announces Acquisition of Seven Data Centers from vXchnge
The Locations Include Nashville, New Jersey, Philadelphia, Pittsburgh, Portland, St. Louis, and St. Paul, Increasing…
One-Third of Houses for Sale Are New Construction, an All-Time High
The share of newly built single-family homes on the market is at a record high…
Associated Wholesale Grocers and IRI Partner to Launch AWG Partner Gateway
KANSAS CITY, Kan. & CHICAGO–(BUSINESS WIRE)–Associated Wholesale Grocers, Inc. (AWG), the nation’s largest cooperative food…
Otterbourg Promotes Jennifer Feeney and Pauline McTernan to Members of the Firm
NEW YORK–(BUSINESS WIRE)–Otterbourg P.C. announced today that Jennifer Feeney and Pauline McTernan have been promoted…
OSE Immunotherapeutics Announces Acceptance of the US Investigational New Drug (IND) Application Obtained by Veloxis Pharmaceuticals, Inc., its Partner in Transplantation, for CD28 Antagonist VEL-101/FR104
Based on the global license agreement signed in April 2021, this first milestone triggers a…
Changes to the Executive Management of Orphazyme – Anders Vadsholt to be appointed CEO
Orphazyme A/SCompany announcementNo. 03/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, January 31, 2022 – Orphazyme…